EP1305018A4 - Methoden und zusammenstellungen zur prophylaxe und/oder behandlung von diabetes und zur glukoseregulierung - Google Patents

Methoden und zusammenstellungen zur prophylaxe und/oder behandlung von diabetes und zur glukoseregulierung

Info

Publication number
EP1305018A4
EP1305018A4 EP00952402A EP00952402A EP1305018A4 EP 1305018 A4 EP1305018 A4 EP 1305018A4 EP 00952402 A EP00952402 A EP 00952402A EP 00952402 A EP00952402 A EP 00952402A EP 1305018 A4 EP1305018 A4 EP 1305018A4
Authority
EP
European Patent Office
Prior art keywords
diabetes
prevention
compositions
treatment
glucose modulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00952402A
Other languages
English (en)
French (fr)
Other versions
EP1305018A1 (de
Inventor
Michael Menard
Susie Rockway
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PharmaNutrients Inc
Original Assignee
PharmaNutrients Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PharmaNutrients Inc filed Critical PharmaNutrients Inc
Publication of EP1305018A1 publication Critical patent/EP1305018A1/de
Publication of EP1305018A4 publication Critical patent/EP1305018A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
EP00952402A 2000-08-02 2000-08-02 Methoden und zusammenstellungen zur prophylaxe und/oder behandlung von diabetes und zur glukoseregulierung Withdrawn EP1305018A4 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2000/021050 WO2002009693A1 (en) 2000-08-02 2000-08-02 Method and compositions for prevention and/or treatment of diabetes and glucose modulation

Publications (2)

Publication Number Publication Date
EP1305018A1 EP1305018A1 (de) 2003-05-02
EP1305018A4 true EP1305018A4 (de) 2006-08-30

Family

ID=21741654

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00952402A Withdrawn EP1305018A4 (de) 2000-08-02 2000-08-02 Methoden und zusammenstellungen zur prophylaxe und/oder behandlung von diabetes und zur glukoseregulierung

Country Status (4)

Country Link
EP (1) EP1305018A4 (de)
JP (1) JP2004505042A (de)
AU (1) AU2000265109A1 (de)
WO (1) WO2002009693A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1357977B1 (de) 2000-09-21 2004-07-21 Nutrition 21, Inc. Chrom enthaltende zusammensetzung zur behandlung von diabetes, zur verbesserung der insulinsensitivität und zur reduktion von hyperglykämie, hypercholesterolämie und des körperfettanteils
EP1302114A3 (de) * 2001-10-16 2004-01-14 Loders Croklaan B.V. Mischungen zur Förderung der Glucoseaufnahme
US20080004227A1 (en) * 2004-03-01 2008-01-03 Pharmafrontier Co., Ltd Pharmaceutical Composition for Lowering Blood Sugar Level
US7666447B2 (en) 2004-10-08 2010-02-23 Pharmanutrients Compositions including Krill extracts and conjugated linoleic acid and methods of using same
KR101297921B1 (ko) 2006-08-11 2013-08-19 카오카부시키가이샤 유지 조성물
US8809560B2 (en) 2011-05-17 2014-08-19 Board Of Trustees Of The University Of Arkansas Trans-, trans-conjugated linoleic acid compositions and use thereof
ES2395529B1 (es) 2011-06-08 2014-04-11 Pri, S.A. Combinación sinérgica para el tratamiento de la diabetes mellitus tipo 2.
US9897565B1 (en) 2012-09-11 2018-02-20 Aseko, Inc. System and method for optimizing insulin dosages for diabetic subjects
US9171343B1 (en) 2012-09-11 2015-10-27 Aseko, Inc. Means and method for improved glycemic control for diabetic patients
US9062276B2 (en) 2012-12-03 2015-06-23 Board Of Trustees Of The University Of Arkansas Conjugated linoleic acid rich vegetable oil production from linoleic rich oils by heterogeneous catalysis
CN103190611A (zh) * 2013-03-17 2013-07-10 王伟 一种具有降糖功能的菊花胶囊及其制备方法
US20150056297A1 (en) * 2013-08-26 2015-02-26 Charles H. Liu Nutraceutical combination for prevention and treatment of type 2 diabetes
US9898585B2 (en) 2014-01-31 2018-02-20 Aseko, Inc. Method and system for insulin management
US9486580B2 (en) 2014-01-31 2016-11-08 Aseko, Inc. Insulin management
US11081226B2 (en) 2014-10-27 2021-08-03 Aseko, Inc. Method and controller for administering recommended insulin dosages to a patient
US9892234B2 (en) 2014-10-27 2018-02-13 Aseko, Inc. Subcutaneous outpatient management
EP3337402A4 (de) 2015-08-20 2019-04-24 Aseko, Inc. Therapieberater für diabetesmanagement
CN107243043A (zh) * 2017-08-17 2017-10-13 刘明州 一种治疗糖尿病和控制其并发症发生的中药

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0265772A2 (de) * 1986-10-27 1988-05-04 Abbott Laboratories Flüssige Nährwert-Tabelle für Glukose-Intoleranz
WO1998033494A1 (en) * 1997-02-04 1998-08-06 Kosbab John V Compositions and methods for prevention and treatment of vascular degenerative diseases
WO1998042211A2 (en) * 1997-03-24 1998-10-01 Progressive Research Labs Nutritional supplements for improving glucose metabolism
US5976548A (en) * 1994-11-08 1999-11-02 Viva America Marketing, Inc. Nutritional supplement composition and use
WO2000012080A1 (en) * 1998-09-01 2000-03-09 Amway Corporation Diet composition and method of weight management
US6063820A (en) * 1997-03-20 2000-05-16 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Medical food for diabetics

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1911999A (en) * 1997-12-12 1999-06-28 Penn State Research Foundation, The Methods and compositions for treating diabetes

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0265772A2 (de) * 1986-10-27 1988-05-04 Abbott Laboratories Flüssige Nährwert-Tabelle für Glukose-Intoleranz
US5976548A (en) * 1994-11-08 1999-11-02 Viva America Marketing, Inc. Nutritional supplement composition and use
WO1998033494A1 (en) * 1997-02-04 1998-08-06 Kosbab John V Compositions and methods for prevention and treatment of vascular degenerative diseases
US6063820A (en) * 1997-03-20 2000-05-16 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Medical food for diabetics
WO1998042211A2 (en) * 1997-03-24 1998-10-01 Progressive Research Labs Nutritional supplements for improving glucose metabolism
WO2000012080A1 (en) * 1998-09-01 2000-03-09 Amway Corporation Diet composition and method of weight management

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
MCCARTY M F ET AL: "Rationales for micronutrient supplementation in diabetes.", MEDICAL HYPOTHESES. FEB 1984, vol. 13, no. 2, February 1984 (1984-02-01), pages 139 - 151, XP009069813, ISSN: 0306-9877 *
MCCARTY M F: "TOWARD A WHOLLY NUTRITIONAL THERAPY FOR TYPE 2 DIABETES", MEDICAL HYPOTHESES, EDEN PRESS, PENRITH, US, vol. 54, no. 3, March 2000 (2000-03-01), pages 483 - 487, XP001105930, ISSN: 0306-9877 *
PELTON R: "SUPPLEMENTS CAN FORESTALL DIABETES COMPLICATIONS WITH 64 MILLION DIABETES-RELATED SCRIPTS DISPENSED EACH YEAR, OPPORTUNITIES FOR NUTRITIONAL COUNSELING ABOUND", AMERICAN DRUGGIST, vol. 216, no. 8, 1999, pages 52 - 53, XP000908773, ISSN: 0190-5279 *
See also references of WO0209693A1 *

Also Published As

Publication number Publication date
WO2002009693A1 (en) 2002-02-07
JP2004505042A (ja) 2004-02-19
EP1305018A1 (de) 2003-05-02
AU2000265109A1 (en) 2002-02-13

Similar Documents

Publication Publication Date Title
EP1305018A4 (de) Methoden und zusammenstellungen zur prophylaxe und/oder behandlung von diabetes und zur glukoseregulierung
PT1231887E (pt) Método e composição para o tratamento de cicatrizes
IL157327A0 (en) Composition and methods for modulation of vascular structure and/or function
MXPA01009415A (es) COMPOSICION DE ACIDO ASCORBICO Y METODO PARA TRATAMIENTO DE PIEL DAnADA O ENVEJECIDA.
PL364995A1 (en) Method for the treatment or prevention of flavivirus
AUPR638101A0 (en) Composition and method for treatment of disease
GB0110288D0 (en) Composition and treatment method
AU5339201A (en) Compositions for reducing hypercholesterolemia and controlling of postprandial blood glucose and insulin levels
MXPA03006043A (es) Metodos que emplean y composiciones que contienen moleculas asociadas en placa para la prevencion y el tratamiento de la aterosclerosis.
AU2002231095A1 (en) Method and composition for the treatment of diabetic neuropathy
AU1794801A (en) Method for treatment and prevention of physiological shock
PL348049A1 (en) Pyridinium derivatives for the treatment of diabetic and aging−related vascular complications
EP1089731A4 (de) Zusammensetzungen und verfahren zur behandlung von erhöhtem blutcholesterolspiegel
GB2343844B (en) Composition and method for treatment of hypertrophic skin accumlations and their prevention
AU2003231279A1 (en) Prevention and treatment of type 2 diabetes
GB2399500B (en) Composition and method for treatment of wounds
AU2001273759A1 (en) Essential oils and chemically related species for the treatment of increased bone resorption
HUP0203676A3 (en) Pharmaceutical composition and method for treatment of diabetes
AU2002230509A1 (en) Devices and methods for treating low blood sugar levels
HUP0300043A3 (en) Method and composition for the treatment of pain
EP1089732A4 (de) Zusammenstellungen und methoden zur behandlung von erhöhtem blutcholesterolspiegel
AU2002322862A1 (en) Methods and compositions for diagnosis and treatment of vascular conditions
GB9928681D0 (en) Method and composition for treatment or prophylaxis of diabetes
AU6622600A (en) Low concentration pest treatment composition and method
AU2001247546A1 (en) Method and composition for treatment and prevention of alopecia

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20030128

AK Designated contracting states

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

A4 Supplementary search report drawn up and despatched

Effective date: 20060728

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 3/10 20060101ALI20060725BHEP

Ipc: A61K 33/24 20060101ALI20060725BHEP

Ipc: A61K 31/201 20060101AFI20060725BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20061027